Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Episurf Medical ABOSTO:EPIS B +1.27% Net Margin % is -896.67% as of Mar. 2026. The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Episurf Medical AB ranks worse than 92.03% on this metric.
The historical rank and industry rank for Episurf Medical AB's Net Margin % or its related term are showing as below:
OSTO:EPIS B'
s Net Margin % Range Over the Past 10 Years
Min: -2563.05 Med: -1224.61 Max: -431.11
Current: -543.65
OSTO:EPIS B's Net Margin % is ranked worse than 92.03% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 2.11
vs OSTO:EPIS B: -543.65
Episurf Medical AB (OSTO:EPIS B) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Episurf Medical AB Net Margin % Related Terms
Episurf Medical AB Net Margin % Historical Data
* Premium members only.
The historical data trend for Episurf Medical AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:EPIS B vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Episurf Medical AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Episurf Medical AB Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Episurf Medical AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where Episurf Medical AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Episurf Medical AB (OSTO:EPIS B) has a Net Margin % of -896.67% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Episurf Medical AB and its competitors. According to the industry distribution chart, Episurf Medical AB ranks #751 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 92%.
Is Episurf Medical AB's Net Margin % too high?
Episurf Medical AB's current Net Margin % is -896.67%. Based on the distribution chart, Episurf Medical AB ranks #751 out of 816 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Episurf Medical AB's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Episurf Medical AB ranks #751 out of 816 companies for Net Margin %. This places Episurf Medical AB in the lower half of its industry. The industry median Net Margin % is 2.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.11, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Episurf Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Episurf Medical AB's current Net Margin % is -896.67%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Episurf Medical AB stock overvalued right now?
Based on GuruFocus' analysis, Episurf Medical AB (OSTO:EPIS B) is currently considered Modestly Overvalued. The stock's GF Value™ is kr0.05, compared to a current price of kr0.06 — trading 11.8% above its estimated fair value. The current Net Margin % is -896.67%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Episurf Medical AB (OSTO:EPIS B), the current Net Margin % is -896.67% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Episurf Medical AB is a medical device company. The company develops, manufactures, and commercializes solutions for the repair of the local cartilage damage in human joints. Its first patient-specific product portfolio, the knee portfolio, consists of the existing products Episealer Condyle Solo and Episealer Trochlea Solo, Episealer Femoral Twin, Epiguide MOS, and Epioscopy. Episealer Patellofemoral System for the treatment of osteoarthritis limited to thepatellofemoral part of the knee joint. The company is forming a new strategic business segment through the acquisition of real estate assets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:EPIS B has been successfully added to your 
